Background: HIV-syphilis co-infection is a combination that enhances rapid progression of early syphilis or late latent syphilis to neurosyphilis and can cause catastrophic neurological complications. In studies in Mwanza, syphilis affects ~8% of healthy outpatients, and older studies have suggested that up to 23.5% of HIV-syphilis co-infected patients also have neurosyphilis. The study aimed at determining the prevalence of syphilis, neurosyphilis and associated factors among HIV infected patients attending Bugando Medical Center.
Methods: This was a cross sectional study in which HIV infected patients who were hospitalized or attending the outpatient Care and Treatment Clinic (CTC) were interviewed using structured questionnaire and screened for syphilis using serum Treponema Pallidum hemagglutination assay (TPHA). We included all HIV-infected persons aged 18 years and above who consented. Blood was also taken for CD4+ T cells and viral load. Those who were found to have syphilis underwent neurological examination for any neurologic deficit and offered lumbar puncture.
Results: The prevalence of syphilis in HIV infected patients was found to be 9.6%. The majority of these were female (72.5%) and median age was 42 years [interquartile range, 32-50]. Most patients were on ART (99.4%).The majority of participants with syphilis (89.2%) reported not knowing that they had syphilis, and had not previously been treated. One hundred forty one participants with syphilis had neurological examinations performed, 4 of whom had abnormal findings that necessitated that they undergo lumbar puncture. One of these had confirmed neurosyphilis.
Conclusion: The high prevalence of syphilis in HIV infected patients indicates that there is a need to increase efforts in targeting this population to reduce sexually transmitted infections. Screening for syphilis should be done for all HIV patients given the high prevalence of the infection and the risk that aggressive forms of neurosyphilis can occur despite recovery of CD4+Tcell counts in untreated syphilis.

Figure 1

Figure 2
This is a list of supplementary files associated with this preprint. Click to download.
Loading...
On 28 Nov, 2020
On 25 Nov, 2020
On 15 Nov, 2020
On 10 Feb, 2020
On 09 Feb, 2020
On 09 Feb, 2020
On 20 Jan, 2020
Received 16 Jan, 2020
On 07 Jan, 2020
Received 07 Jan, 2020
Invitations sent on 05 Jan, 2020
On 05 Jan, 2020
On 03 Jan, 2020
On 02 Jan, 2020
On 31 Dec, 2019
Posted 22 Aug, 2019
On 24 Nov, 2019
Received 22 Nov, 2019
On 10 Nov, 2019
Received 27 Sep, 2019
On 05 Sep, 2019
Invitations sent on 05 Sep, 2019
On 22 Aug, 2019
On 19 Aug, 2019
On 19 Aug, 2019
On 12 Aug, 2019
On 28 Nov, 2020
On 25 Nov, 2020
On 15 Nov, 2020
On 10 Feb, 2020
On 09 Feb, 2020
On 09 Feb, 2020
On 20 Jan, 2020
Received 16 Jan, 2020
On 07 Jan, 2020
Received 07 Jan, 2020
Invitations sent on 05 Jan, 2020
On 05 Jan, 2020
On 03 Jan, 2020
On 02 Jan, 2020
On 31 Dec, 2019
Posted 22 Aug, 2019
On 24 Nov, 2019
Received 22 Nov, 2019
On 10 Nov, 2019
Received 27 Sep, 2019
On 05 Sep, 2019
Invitations sent on 05 Sep, 2019
On 22 Aug, 2019
On 19 Aug, 2019
On 19 Aug, 2019
On 12 Aug, 2019
Background: HIV-syphilis co-infection is a combination that enhances rapid progression of early syphilis or late latent syphilis to neurosyphilis and can cause catastrophic neurological complications. In studies in Mwanza, syphilis affects ~8% of healthy outpatients, and older studies have suggested that up to 23.5% of HIV-syphilis co-infected patients also have neurosyphilis. The study aimed at determining the prevalence of syphilis, neurosyphilis and associated factors among HIV infected patients attending Bugando Medical Center.
Methods: This was a cross sectional study in which HIV infected patients who were hospitalized or attending the outpatient Care and Treatment Clinic (CTC) were interviewed using structured questionnaire and screened for syphilis using serum Treponema Pallidum hemagglutination assay (TPHA). We included all HIV-infected persons aged 18 years and above who consented. Blood was also taken for CD4+ T cells and viral load. Those who were found to have syphilis underwent neurological examination for any neurologic deficit and offered lumbar puncture.
Results: The prevalence of syphilis in HIV infected patients was found to be 9.6%. The majority of these were female (72.5%) and median age was 42 years [interquartile range, 32-50]. Most patients were on ART (99.4%).The majority of participants with syphilis (89.2%) reported not knowing that they had syphilis, and had not previously been treated. One hundred forty one participants with syphilis had neurological examinations performed, 4 of whom had abnormal findings that necessitated that they undergo lumbar puncture. One of these had confirmed neurosyphilis.
Conclusion: The high prevalence of syphilis in HIV infected patients indicates that there is a need to increase efforts in targeting this population to reduce sexually transmitted infections. Screening for syphilis should be done for all HIV patients given the high prevalence of the infection and the risk that aggressive forms of neurosyphilis can occur despite recovery of CD4+Tcell counts in untreated syphilis.

Figure 1

Figure 2
This is a list of supplementary files associated with this preprint. Click to download.
Loading...